Thirty years of half-products. Lumagen is the whole thing.

Intake, pedigree, criteria, risk models and recontact in one system.

What the incumbents leave you

  • A better canvas, and the same hour on the phone.Drawing was solved a decade ago. Collecting the history was not, and that is the barrier to more productive and more personable clinicians.
  • A form only captures what it thought to ask.Forms are fine for the patient who knows every date. Family history usually arrives vague and half-remembered, and the nuance lives in the follow-up: which side, roughly what age, how sure are you. A conversation records that. A fixed set of fields records a blank.
  • None re-read the cases you closed.Criteria moved more than thirty times since 2020. The patient who did not qualify in 2019 may qualify today, and no product on the market will tell the organization which one.

Let us know a bit about you, and we will reach out soon.

No patient information on this form. By submitting you agree to our privacy policy.

LumaGen

A modern platform for the modern oncology clinician.

Draw one pedigree and see

© 2026 LumaGen, a product of Helix Reserve LLC|PrivacyTermsContactLumaGen supports clinical decisions. It does not make them, and it is not a diagnostic device.